Literature DB >> 20155800

Hydroxychloroquine for subglottic stenosis: a novel therapy in the battle for air.

Nir Hirshoren1, Ron Eliashar, Jeffrey M Weinberger.   

Abstract

Upper airway obstruction due to subglottic edema and granulation tissue proliferation may cause severe morbidity and may be life threatening. Hydroxychloroquine interferes with antigen processing by means of raising lysosomal pH and immune response modulation. Herein, we present the outcome of a steroid-sparing treatment using hydroxychloroquine in an 80-year-old man with acquired subglottic stenosis and steroid dependency. Twice daily oral hydroxychloroquine at 2 mg/kg/day allowed cessation of systemic steroids without recurrence of the stenosis. Successful weaning of the hydroxychloroquine took place over a 5-month period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155800     DOI: 10.1002/lary.20848

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Chronic non-granulomatous supraglottitis of a male adolescent and its successful management with azathioprine.

Authors:  Aaron Kovacs; Shankar Haran; Paul Paddle
Journal:  BMJ Case Rep       Date:  2019-04-03

2.  Role of Topical Medication in Prevention of Post-extubation Subglottic Stenosis.

Authors:  Saravanam Prasanna Kumar; Arunachalam Ravikumar; Johnson Thanka
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-17

Review 3.  Hydroxychloroquine: from malaria to autoimmunity.

Authors:  Ilan Ben-Zvi; Shaye Kivity; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Hydroxychloroquine as treatment for inflammatory subglottic stenosis: a second successful case.

Authors:  G Desuter; A Gregoire; Q Gardiner; F Houssiau
Journal:  Case Rep Otolaryngol       Date:  2012-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.